Financial Statements · Financial Reporting
PharmaSynth AS
Official identifier 11044101Record date 31 Dec 2023
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2023
- Period start
- 1 Jan 2023
- Submitted date
- 26 Jun 2024
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 940,779 |
| Balance sheet | Cash and cash equivalents | 658,180 |
| Balance sheet | Current assets | 783,422 |
| Balance sheet | Current liabilities | 44,535 |
| Balance sheet | Equity | 896,244 |
| Balance sheet | Share capital at nominal value | 57,180 |
| Balance sheet | Non-current assets | 157,357 |
| Balance sheet | Retained earnings (loss) from previous periods | 687,489 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -51,022 |
| Income statement scheme 1 | Labour costs | -297,674 |
| Income statement scheme 1 | Revenue | 635,352 |
| Income statement scheme 1 | Annual period profit / loss | 145,484 |
| Income statement scheme 1 | Operating profit (loss) | 153,209 |
| Income statement scheme 1 | Profit (loss) before income tax | 145,484 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 687,489 |
| Note: Labour costs | Employees | 7 |
| Note: Labour costs | Labour costs | 297,674 |
Linked company
Company: PharmaSynth AS